Nocturnal Leg Cramps
7
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
1 terminated out of 7 trials
80.0%
-6.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Effect of Vitamin K2 in the Treatment of Nocturnal Leg Cramps in Older Population
Exercise and Dry Needling Treatment Combination in Nocturnal Calf Cramps
Extracorporeal Shock Wave Therapy Treatment for Nocturnal Leg Cramps
The Study of Efficacy and Safety of a 60-day Use of the Magnox Comfort Compared to the Placebo in Subjects With NLC
Nocturnal Leg Cramps in Geneva : an Observational Study
Magnesium Oxide Monohydrate for Nocturnal Leg Cramps
The Effects of the Myofascial Trigger Point Injections on Pain and Sleep Disturbance in Patients With Nocturnal Leg Cramps With Trigger Points on Gastrocnemius Muscle